Abilify and Sandostatin lar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Sandostatin lar (octreotide acetate). Common drug interactions include paronychia among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Sandostatin lar. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,455 Abilify users. Check the latest studies of Abilify.

What is Sandostatin lar?

Sandostatin lar has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 38,437 Sandostatin lar users. Check the latest studies of Sandostatin lar.

On Aug, 10, 2026

24 people who take Abilify and Sandostatin lar together, and have interactions are studied.

Abilify and Sandostatin lar drug interactions.

What are the common drug interactions of Abilify and Sandostatin Lar, by gender? *:

female:

Paronychia (infection in the tissues adjacent to a nail on a finger or toe)
Periorbital oedema (swelling around the eyes)
Peripheral swelling
Pneumonia
Proctalgia (pain in the rectum)
Protein urine
Pruritus (severe itching of the skin)
Rectal fissure (painful condition in which a cut or tear occurs in the anus)
Rosacea (a skin condition that causes facial redness)
Scab (a hard coating on the skin formed during the wound healing)

male:

Vomiting
Blood pressure increased
Eructation (release of gas from the digestive tract)
Heart rate decreased
Heart rate increased
Hyperhidrosis (abnormally increased sweating)
Nervousness
Syncope (loss of consciousness with an inability to maintain postural tone)
Haematochezia (passage of stools containing blood)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)

What are the common drug interactions of Abilify and Sandostatin Lar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Blood pressure increased
Chills (felling of cold)
Cold sweat
Diarrhoea
Diarrhoea haemorrhagic (bloody diarrhoea)
Dizziness
Eructation (release of gas from the digestive tract)
Fatigue (feeling of tiredness)
Heart rate decreased
Heart rate increased

40-49:

n/a

50-59:

Rosacea (a skin condition that causes facial redness)
Scab (a hard coating on the skin formed during the wound healing)
Secretion discharge
Sensitisation (the state of being sensitive)
Sinusitis (inflammation of sinus)
Skin irritation
Skin sensitisation (sensitive skin)
Sputum discoloured
Swelling
Tendonitis (a condition that causes pain and swelling of tendons)

60+:

Fall
Blood pressure increased
Dizziness
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Head injury
Intestinal obstruction
Mobility decreased (ability to move is reduced)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pneumonia
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

What are the existing conditions these people have? *

Neuroendocrine Tumor: 11 people, 45.83%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 16.67%
Psychotic Disorder: 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Sandostatin lar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously